Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Financing Article
This is a selection made from among articles on Drug Treatment Financing. For a permanent link to this article, or to bookmark it for future reading, click here.
Drug Addiction Recovery
from:Many people struggling with drug addiction think that recovery is nearly impossible for them. They’ve heard the horror stories of painful withdrawal symptoms, they can’t imagine life without drugs, and they can’t fathom actually being able to get through a recovery effort. But people do recover from drug addiction – every day in fact. But they don’t usually do it alone. They have lots of help.
Help with drug addiction recovery can come from many different places in the form of loving family and friends, drug treatment programs, and drug rehab facilities. Recovery is a long process that requires a commitment from a lot of people, but when you get help with your drug addiction, recovery is a very real possibility.
Drug addiction recovery entails more than just getting over the physical withdrawal from drugs, it also involves a healing of the mind and the mindset that started you towards drug addiction in the first place. Recovery is a spiritual process that needs to take place in the mind, heart, and soul.
Recovery comes about after a long period of time. The initial phase is abstinence or not using the drug. Abstinence eventually moves into recovery as the addict begins to change and grow in positive ways. Abstinence requires a decision, recovery requires effort.
Once you have gone through the abstinence phase with withdrawal from the drug, you can then move on to mental recovery. This type of recovery has to do with issues like brain function and brain chemistry. It involves changing your attitudes, belief systems, and rational thoughts so that you don’t start using drugs again.
Emotional recovery from drugs is a very complex part of the healing process as well. This part of recovery has more to do with your feelings than anything else. Emotional recovery involves learning to deal with feelings openly, honestly, and responsibly. It includes learning to express and resolve feelings in appropriate and effective ways. For most people in recovery, emotional recovery can take years.
Finally, you’ll need to recover from drug addiction spiritually. Even if you are not a religious person, spiritual recovery has more to do with your attitude toward life and how you want to live that life. When you begin to recover spiritually, the way you look at the world changes: fear is replaced by faith, self-pity turns to gratitude, resentment becomes acceptance, and dishonesty turns to honesty.
You can choose to undertake your drug addiction recovery at a rehab facility or through a 12-step program, but you truly do need to seek out the help of others if you want to have a full recovery. Very few people are able to recover from drug addiction on their own. Don’t be afraid to ask for help because you can have a successful recovery from drug addiction once you do!
Drug Treatment Financing Specific links
Drug Treatment Financing News
Addiction Diagnoses May Rise Under Guideline Changes - New York Times
 New York Times | Addiction Diagnoses May Rise Under Guideline Changes New York Times WASHINGTON — In what could prove to be one of their most far-reaching decisions, psychiatrists and other specialists who are rewriting the manual that serves as the nation's arbiter of mental illness have agreed to revise the definition of addiction, ... Revised definition of 'addiction' may spur hike in number of addicts Revised guidelines might sharply increase addiction diagnoses You could be addicted but not know it |
Remedying Global Health R&D - Analysis - Eurasia Review
 Eurasia Review | Remedying Global Health R&D - Analysis Eurasia Review Health experts working far from industry labs have long called for products that can hold up in the field, are easy to administer in places with few trained health workers, and treat diseases prevalent in poor countries. But an MSF survey of drugs ... |
Business Briefs for May 27, 2012 - The Advocate
Business Briefs for May 27, 2012 The Advocate Baton Rouge biotechnology firm Esperance Pharmaceuticals said it is starting a Phase 2 trial of a drug designed to attack cancer by targeting a potential treatment for advanced ovarian cancer. The molecular structure of Esperance's drug, called EP-100, ... |
Cellceutix Arranges $1 Million Financing for Clinical Trials of New Cancer ... - MarketWatch (press release)
Cellceutix Arranges $1 Million Financing for Clinical Trials of New Cancer ... MarketWatch (press release) BEVERLY, MA, May 14, 2012 (MARKETWIRE via COMTEX) -- Cellceutix Corporation (OBB:CTIX) (the "Company"), a biopharmaceutical company developing a novel drug to treat cancers and cancers which have proven resistant to today's cancer therapies ... Cellceutix IND Filing Imminent after Capital Raise |
Cytokinetics Announces Opening of Second Cohort in Phase IIb Clinical Trial of ... - MarketWatch (press release)
Cytokinetics Announces Opening of Second Cohort in Phase IIb Clinical Trial of ... MarketWatch (press release) Cytokinetics' lead drug candidate from its cardiac muscle contractility program, omecamtiv mecarbil, is in Phase II clinical development for the potential treatment of heart failure. Amgen Inc. holds an exclusive license worldwide (excluding Japan) to ... |
MedX Health Evaluating Options for $1M Financing - Stockhouse
MedX Health Evaluating Options for $1M Financing Stockhouse MDX) with worldwide revenues in drug free, non-invasive low level laser light therapy and light imaging systems, announced today that they are withdrawing the original private placement announced on April 2, 2012 and evaluating a number of financing ... |
FDA User Fees Use Consumers Badly - Forbes
 Forbes | FDA User Fees Use Consumers Badly Forbes The fees, which constitute a large chunk of FDA's budget – about 65 percent of the cost of reviewing drug applications and about a quarter of the agency's total spending – enable Congress to finance much of the agency's work “off the books. |
Retrophin, LLC Completes Series A Financing - MarketWatch (press release)
Retrophin, LLC Completes Series A Financing MarketWatch (press release) The company intends to invest the proceeds from the Series A financing to advance its pipeline of novel rare-disease drug candidates, including a proof-of-concept study of RE-021 (a dual acting receptor antagonist of Angiotensin and Endothelin ... |
Genta Announces Results of Tesetaxel Confirmatory Trial in Patients With ... - MarketWatch (press release)
Genta Announces Results of Tesetaxel Confirmatory Trial in Patients With ... MarketWatch (press release) BERKELEY HEIGHTS, NJ, May 24, 2012 (GLOBE NEWSWIRE) -- Genta Incorporated (GNTA) today announced results from the Company's Phase 2, confirmatory, clinical trial of tesetaxel as 2nd-line treatment of patients with advanced gastric cancer. |
MediciNova Reports Results of a Phase 2b Clinical Trial of MN-221 in Asthma ... - FierceBiotech
MediciNova Reports Results of a Phase 2b Clinical Trial of MN-221 in Asthma ... FierceBiotech The trial also demonstrated a reduction in hospital admissions with MN-221 added to standard drug treatments. Moreover, there was a significant improvement in clinical symptoms with MN-221 treated patients and the safety profile of MN-221 continues to ... |